The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review.

ABSTRACT: Cardiovascular diseases are currently among the leading causes of morbidity and mortality in many developed countries. They are distinguished by chronic and latent development, a course with stages of worsening of symptoms and a period of improvement, and a constant potential threat to life. One of the most important disorders in cardiovascular disease is ischemic stroke. The causes of ischemic stroke can be divided into non-modifiable and modifiable causes. One treatment modality from a neurological point of view is acetylsalicylic acid (ASA), which blocks cyclooxygenase and, thus, thromboxane synthesis. The legitimacy of its administration does not raise any doubts in the case of the acute phase of stroke in patients in whom thrombolytic treatment cannot be initiated. The measurement of

SUBMITTER: Szczuko M 

PROVIDER: S-EPMC8584264 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature